(R)-2-((4E,6E)-(2S,3S)-3-Acetylamino-2,6-dimethyl-10-phenyl-deca-4,6-dienoylamino)-propionic acid

ID: ALA97878

Chembl Id: CHEMBL97878

PubChem CID: 44330465

Max Phase: Preclinical

Molecular Formula: C23H32N2O4

Molecular Weight: 400.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](/C=C/C(C)=C/CCCc1ccccc1)[C@H](C)C(=O)N[C@H](C)C(=O)O

Standard InChI:  InChI=1S/C23H32N2O4/c1-16(10-8-9-13-20-11-6-5-7-12-20)14-15-21(25-19(4)26)17(2)22(27)24-18(3)23(28)29/h5-7,10-12,14-15,17-18,21H,8-9,13H2,1-4H3,(H,24,27)(H,25,26)(H,28,29)/b15-14+,16-10+/t17-,18+,21-/m0/s1

Standard InChI Key:  WXJZLGUUHYFSAT-XGKUTQISSA-N

Associated Targets(Human)

PPM1B Tchem Protein phosphatase 2C beta (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PPP2CA Serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 400.52Molecular Weight (Monoisotopic): 400.2362AlogP: 3.24#Rotatable Bonds: 11
Polar Surface Area: 95.50Molecular Species: ACIDHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.87CX Basic pKa: CX LogP: 3.33CX LogD: 0.10
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.39Np Likeness Score: 0.76

References

1. Gulledge BM, Aggen JB, Eng H, Sweimeh K, Chamberlin AR..  (2003)  Microcystin analogues comprised only of Adda and a single additional amino acid retain moderate activity as PP1/PP2A inhibitors.,  13  (17): [PMID:14611855] [10.1016/s0960-894x(03)00588-2]

Source